v3.26.1
Share-Based Compensation
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation

11. Share-Based Compensation

The Company adopted on August 10, 2022, and the stockholders approved on August 18, 2022, the 2022 Stock Plan. On April 22, 2026, the Company adopted the 2026 Equity and Incentive Compensation Plan (the “Plan”) and on June 22, 2026, the stockholders approved the Plan. The Plan provides for the grant of stock options (including stock options intended to be “incentive stock options” as defined in Section 422 of the Code), appreciation rights, restricted stock, RSUs, performance shares, performance units, cash incentive awards and certain other awards based on or related to shares of the Company’s common stock.

As of June 30, 2026 and December 31, 2025, there were 1,938,756 and 328,442 shares available for future issuance under the Plan, respectively.

Stock-based compensation expense is recognized in the condensed consolidated statements of operations as follows:

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

(in thousands of dollars)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development

 

$

111

 

 

$

116

 

 

$

218

 

 

$

200

 

General and administrative

 

 

596

 

 

 

613

 

 

 

1,183

 

 

 

1,080

 

Total stock-based compensation expense

 

$

707

 

 

$

729

 

 

$

1,401

 

 

$

1,280

 

Unrecognized stock-based compensation costs related to unvested awards and the weighted-average period over which the costs are expected to be recognized as of June 30, 2026, are as follows:

 

Stock Options

 

Unrecognized stock-based compensation expense (in thousands)

 

$

3,867

 

Expected weighted-average period compensation costs to be recognized (years)

 

 

2.1

 

A summary of the Company’s stock option activity is as follows:

 

Stock Options

 

 

Weighted-Average Exercise Price per Share

 

 

Weighted-Average Remaining Contractual Life (years)

 

 

Aggregate Intrinsic Value (in thousands)

 

Outstanding as of December 31, 2025

 

 

285,801

 

 

$

47.80

 

 

 

8.0

 

 

$

 

Granted

 

 

400,443

 

 

$

1.19

 

 

 

 

 

$

 

Exercised

 

 

 

 

$

 

 

 

 

 

$

 

Forfeited/canceled

 

 

 

 

$

 

 

 

 

 

$

 

Outstanding as of June 30, 2026

 

 

686,244

 

 

$

20.63

 

 

 

8.9

 

 

$

 

Exercisable as of June 30, 2026

 

188,259

 

 

$

49.65

 

 

 

7.1

 

 

$

 

The fair value of stock options granted to employees, directors, and consultants was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted-average assumptions:

Assumptions:

 

Six Months Ended
June 30, 2026

Risk-free interest rate

 

4.23%

Expected volatility

 

110.53%

Expected term (years)

 

7.00

Expected dividend

 

N/A

 

The weighted-average grant date fair value of the options granted during the six months ended June 30, 2026 and 2025 was $1.04 per share and $0.87 per share, respectively.